This counteraction between ALOX15B and ALOX5 indicates an essential switch between pro- and anti-inflammatory precursors, as evidenced in studies of cystic fibrosis macrophages [106] and prostate cancer cells [107]. This evidence concerns the gene ALOX5 and prostate cancer.